SCHEMBL10520260

SCHEMBL10520260

CCCCCSC[C@H](N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)OC(C)(C)C)C(=O)OCC

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 10/20 0.45
▸ LMNA P02545 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ ABCB11 O95342 1/20 0.33
▸ FKBP1A P62942 2/20 0.33
▸ ACE2 Q9BYF1 1/20 0.33
▸ POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10520254 1.00 ACE (0.45) ACELMNASMN1; SMN2MEN1KMT2A
SCHEMBL10521977 0.99 ACE (0.44) ACELMNASMN1; SMN2MEN1KMT2A
SCHEMBL10521974 0.99 ACE (0.44) ACELMNASMN1; SMN2MEN1KMT2A
SCHEMBL10383380 0.88 ACE (0.46) ACELMNASMN1; SMN2MEN1KMT2A
SCHEMBL10523310 0.88 ACE (0.56) ACELMNASMN1; SMN2ACE2
SCHEMBL10523303 0.88 ACE (0.56) ACELMNASMN1; SMN2ACE2
SCHEMBL10522076 0.85 ACE (0.60) ACELMNASMN1; SMN2ACE2
SCHEMBL10522090 0.85 ACE (0.60) ACELMNASMN1; SMN2ACE2
SCHEMBL10796212 0.85 ACE (0.60) ACELMNASMN1; SMN2ACE2
SCHEMBL10935341 0.84 CYP1A2 (0.50) ACELMNASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4886813-A INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1989-12-12 — — US disclosed
Send feedback